The aim of this article is to summarise the evidence for the use of PBA in maintaining functional access circuits.Ī narrative review of the literature was performed using Medline and Embase via Ovid to include studies published from 1980 to 2022. In keeping with the latest KDOQI guidelines, the use of PBA must be factored in as part of the overall, individual patient’s pathway and long-term care of each patient (the ESKD (End Stage Kidney Disease) Life Plan). Angioplasty also has the added advantage of allowing treatment of synchronous lesions. Although the outcomes of surgical revision have been shown to be comparable to angioplasty, the use of angioplasty can prolong the life of a fistula whilst preserving the option of surgical revision. Clinical manifestation of access dysfunction manifest broadly as disorders of inflow (needling difficulty, inability to achieve adequate dialysis flow speed, and poor fistula maturation) or outflow (arm swelling and prolonged bleeding). Plain balloon angioplasty (PBA), typically with high-pressure balloons, is considered to be the mainstay of treatment for dialysis access circuit stenoses and is indicated when there is an angiographically significant stenosis associated with clinical dysfunction. These outcomes all lead to significant morbidity and result in substantial economic cost. Stenosis can develop in the access circuit due to multiple factors and if untreated, can lead to reduced effectiveness of dialysis, progressive loss of function and thrombosis of the access circuit. However, preserving the patency of these accesses remains challenging. These are the most established means of long-term haemodialysis. This was followed by the introduction of expanded polytetrafluorethylene (ePTFE) grafts into clinical practice in 1976. AngioSculpt can be used in treating fibro-calcific, bifurcation and ostial lesions.Subcutaneous arteriovenous fistulae were developed by Brescio and Cimino in 1966, providing vascular access for haemodialysis. The AngioSculpt Scoring Balloon Catheter is a new tool in the treatment of simple to complex lesions, including in-stent restenosis (ISR) and type C lesions. Originally developed by AngioScore,ĪngioSculpt Percutaneous Transluminal Coronary Angioplasty (PTCA) Scoring Balloon Catheter Ts AngioSculptX Drug-coated PTCA (percutaneous transluminal coronary angioplasty) Scoring Balloon Catheter. We describe the entrapment of an AngioSculpt PTCA balloon catheter during the predilatation of a heavily calcified lesion, analyzing the possible causal mechanism. He AngioSculpt PTCA balloon catheter (Angioscore, Inc.) consists of a semirigid balloon surrounded by nitinol spirals, the purpose of which is to dilate and rupture complex atherosclerotic plaques, minimizing slippage of the balloon, as in cases of restenotic, ostial, fibrocalcific, or other types of lesions. The AngioSculpt RX PTCA scoring balloon catheter is the only specialty scoring device indicated for ISR and complex type-C lesions. COOK AMPLATZ ULTRA STIFF GUIDE WIRE (145CM / J TIP)ĪngioSculpt RX PTCA scoring balloon catheter significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide.Cougar Xt Hydro Track Guidewire Medtronic. Asahi Caravel Microcatheter 135cm/150cm.GRAFT INTERGARD WOVEN STRAIGHT(IGW0022-30).ANGIOSCULPT PTCA SCORING BALLOON CATHETER.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |